Eagle Pharmaceuticals, Inc. Forms 3, 4 and 5: Other
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 2 rows, 2 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2016-07-06: Reporting owner Glenning Robert; Form 3; Security No Securities are beneficially owned.; Transaction Holding.
- 2015-04-10: Reporting owner Pernock David; Form 3; Security No securities are currently owned by the Reporting Person; Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2016-07-06 holding as of filing | Glenning Robert Director | 3 | No Securities are beneficially owned. Non-derivative · Direct | Holding | 0 owned after | no price filed | 2016-07-06 | |
| 2015-04-10 holding as of filing | Pernock David Director | 3 | No securities are currently owned by the Reporting Person Non-derivative · Direct | Holding | 0 owned after | no price filed | 2015-04-10 |